RCD advises Reig Jofre on €46 million product portfolio acquisition
RCD acted for pharmaceutical company Reig Jofre on the €46 million acquisition of a portfolio of pharmaceutical and nutraceutical products from Bioibérica.
With the acquisition, Reig Jofre enters the joint health sector and will manage a portfolio of prescription and consumer healthcare products that will generate estimated sales of €26 million.
The RCD team was led by the firm’s head of corporate Adolf Rousaud (pìctured) and included partner Iñaki Frías.